Infections in Two Diet Strategies in HSCT and Leukemia Patients

Infections in Two Diet Strategies in HSCT and Leukemia Patients

Author: American Society of Clinical Oncology (ASCO) April 9, 2026 Duration: 20:40

Guest Dr. John Wingard and host Dr. Davide Soldato discuss JCO article, "Randomized Non-inferiority Trial of a Liberalized Diet Versus the Neutropenic Diet in Hematopoietic Stem Cell Transplant and Acute Leukemia Patients," the reason behind the trial, its design, methodology, results, and the implications for future dietary approaches in hematology.

LINK TO FULL TRANSCRIPT


Hosted by Dr. Davide Soldato, the Journal of Clinical Oncology (JCO) Podcast from the American Society of Clinical Oncology (ASCO) transforms pivotal research into accessible conversation. Each episode focuses directly on a significant study or theme from the latest issue of the Journal of Clinical Oncology, moving from the printed page into a dynamic analysis of what the findings truly mean. Listeners are brought into a detailed scholarly discourse that unpacks methodology, contextualizes results, and debates implications for real-world patient care. This isn't just a summary; it's a critical examination designed for practicing oncologists, fellows, and dedicated healthcare professionals who need to integrate cutting-edge evidence into their daily decisions. The podcast regularly features interviews and in-depth summaries led by the journal's annual fellows, adding fresh, trainee-led perspectives on complex oncology topics. By focusing on the most urgent and practice-changing publications, this podcast serves as an essential audio companion for anyone committed to understanding the rapid evolution of cancer treatment. It’s where rigorous science meets clinical reality, helping the oncology community navigate a constant stream of advancements through informed discussion and expert insight.
Author: Language: English Episodes: 100

Journal of Clinical Oncology (JCO) Podcast
Podcast Episodes
Adjuvant Durvalumab and the Future of Early-Stage NSCLC [not-audio_url] [/not-audio_url]

Duration: 20:04
Guest Dr. Glenwood Goss and host Dr. Davide Soldato discuss JCO article, "Adjuvant Durvalumab in Completely Resected Early-Stage Non-Small Cell Lung Cancer" and the implications of minimal residual disease, results regar…
JCO Article Insights: ctDNA in DLBCL - Ready for Prime Time? [not-audio_url] [/not-audio_url]

Duration: 13:53
In this episode of JCO Article Insights, host Dr. Ash Gurumurthi summarizes JCO articles, "Phased Variant–Supported Circulating Tumor DNA as a Prognostic Biomarker After First-Line Treatment in Large B-Cell Lymphoma: Fin…
NCI Working Group on Biochemically Recurrent Prostate Cancer [not-audio_url] [/not-audio_url]

Duration: 28:15
Host Dr. Davide Soldato and guests Dr. David Einstein and Dr. Ravi Madan discuss JCO article, "National Cancer Institute's Working Group on Biochemically Recurrent Prostate Cancer: Clinical Trial Design Considerations,"…
Association Between EOL SACT and Healthcare Utilization [not-audio_url] [/not-audio_url]

Duration: 23:00
Host Dr. Davide Soldato and guests Dr. Kerin Adelson and Dr. Maureen Canavan discuss JCO article "Association Between Systemic Anticancer Therapy Administration Near the End of Life with Health Care and Hospice Utilizati…
Milan Consensus Endpoints for Bladder Preservation in MIBC [not-audio_url] [/not-audio_url]

Duration: 27:18
Guests Dr. Andrea Necchi, Dr. Ashish Kamat and host Dr. Davide Soldato discuss JCO article "End Points for the Next-Generation Bladder-Sparing Perioperative Trials for Patients With Muscle-Invasive Bladder Cancer," focus…
JCO at 2025 ASH: Pirtobrutinib in Untreated CLL [not-audio_url] [/not-audio_url]

Duration: 20:17
JCO Editor-in-Chief Dr. Jonathan Friedberg is joined by colleagues Dr. Jennifer Woyach, Dr. Wojciech Jurczak, and Dr. Matthew Davids to discuss simultaneous publications presented at ASH 2025 on pertibrutinib, a new upfr…